Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial …

J Zhou, ZY Tang, J Fan, ZQ Wu, Y Ji, YS Xiao… - Clinical cancer …, 2003 - AACR
Purpose: This study was to investigate the effect of capecitabine on recurrent tumor and
metastasis after curative resection of liver cancer, xenograft of a highly metastatic human …

Anti‐metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum

I Ninomiya, I Terada, T Yoshizumi… - … journal of cancer, 2004 - Wiley Online Library
Abstract Capecitabine (N 4‐pentyloxycarbonyl‐5′‐deoxy‐5‐fluorocytidine) is a new
fluoropyrimidine carbamate, which is converted to 5‐fluorouracil (5‐FU) by 3 sequential …

[HTML][HTML] Preparation and application of patient-derived xenograft mice model of colorectal cancer

Y Zhang, Y Yang, L Zan, J Wang, L Yan… - Iranian Journal of …, 2023 - ncbi.nlm.nih.gov
Objective (s): Patient-derived xenograft (PDX) model becomes a more and more important
tool for tumor research. This study aimed to establish a colorectal cancer PDX model and …

Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine

M Rodenbach, E Eyol, MH Seelig… - Journal of cancer research …, 2005 - Springer
Purpose: The aim of this study was to evaluate the combination effect of pemetrexed
disodium (MTA; Alimta; LY 231514) and gemcitabine (GEM) administered by hepatic artery …

[HTML][HTML] Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway

ZJ Liao, YH Guo, Z Zhao, JT Yao… - … journal of oncology, 2014 - spandidos-publications.com
Recurrence and metastasis are responsible for the death of non-small cell lung cancer
(NSCLC) patients. Circulating tumor cells (CTCs) in the metastatic pathway have proven to …

Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an …

RF Hwang, K Yokoi, CD Bucana, R Tsan, JJ Killion… - Clinical Cancer …, 2003 - AACR
Purpose: We evaluated the expression of platelet-derived growth factor (PDGF) ligands and
receptors in clinical specimens of human pancreatic adenocarcinomas and determined the …

Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases

K Jin, H Lan, B Xie, K He, Z Xu, G Li, N Han… - Cancer Biology & …, 2012 - Taylor & Francis
FP3 is an engineered protein which contains the extracellular domain 2 of VEGF receptor 1
(Flt-1) and extracellular domain 3 and 4 of VEGF receptor 2 (Flk-1, KDR) fused to the Fc …

Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by …

CJ Bruns, MT Harbison, DW Davis, CA Portera… - Clinical cancer …, 2000 - AACR
Both epidermal growth factor receptor (EGF-R) signaling mechanisms and angiogenesis
have been evaluated as independent targets for therapy of human pancreatic carcinoma …

Circulating platelet‐derived endothelial cell growth factor increases in hepatocellular carcinoma patients

K Jin‐no, M Tanimizu, I Hyodo… - … Journal of the …, 1998 - Wiley Online Library
BACKGROUND Platelet‐derived endothelial cell growth factor (PD‐ECGF) is an angiogenic
factor that is expressed in various cancer tissues. Little is known regarding plasma PD …

[HTML][HTML] Capecitabine combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts

H Wu, Y Xin, C Xu, Y Xiao - Experimental and …, 2012 - spandidos-publications.com
Low-dose metronomic chemotherapy represents a new strategy to treat solid tumors by
exhibiting stronger anti-angiogenic activity and less side effects, especially in combination …